
Articles
-
3 weeks ago |
onclive.com | Eric Christenson
CommentaryPodcastApril 23, 2025Author(s):Fact checked by:Dr Christenson discusses the capabilities of the Oncodetect test, its clinical applications and pronostic value, and findings from the Alpha-CORRECT study. Welcome to OncLive On Air®! I’m your host today, Ashling Wahner. OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care.
-
2 months ago |
thepilot.com | Eric Christenson
My fellow octogenarians remember when their parents, aunts and uncles went to war against Hitler, Mussolini and Tojo, who were ultra right-wing dictators and bullies bent on reshaping the world to expand their empires. Longtime Pinehurst residents may even remember Gen. George Marshall and his wife, Katherine. In 1944, he bought Liscombe Lodge in Pinehurst so that they could escape cold winters in Leesburg, Virginia. His last full winter in Pinehurst was the winter of 1958-59.
-
Aug 15, 2024 |
onclive.com | Eric Christenson
CommentaryVideoAugust 15, 2024Author(s):Eric S. Christenson, MD, discusses the safety of copanlisib plus nivolumab in pretreated, PIK3Ca-mutated microsatellite stable, unresectable or metastatic colorectal cancer. Eric S.
-
Apr 26, 2024 |
volumeone.org | Eric Christenson
“You think I’m writing these letters for my f****** health?” So starts an Oct. 10, 2022, letter sent from Matthew Mabis to Matt LaFleur, the head coach of the Green Bay Packers. It’s the day after a particularly wrenching loss by the Packers to the New York Giants across the pond in London, and Mabis is stewing. “On the contrary, each one of these damn diatribes forces me to relive the foolishness, and the occasional nuggets of positivity offer no relief.
-
Apr 9, 2024 |
onclive.com | Eric Christenson
Eric S. Christenson, MD, assistant professor of oncology, Johns Hopkins Medicine, discusses findings from a phase 1/2a trial (NCT03711058) of copanlisib (Aliqopa) in combination with nivolumab (Opdivo) in patients with pretreated, microsatellite stable (MSS), unresectable or metastatic colorectal cancer (mCRC).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →